MORE

A Plague Tale: Requiem Passes 1 Million Mark – Developers Celebrate

A Plague Tale: Requiem has been purchased and played by over 1 million players. Developer Focus Entertainment announced the news on Twitterproudly celebrates the milestone and thanks the fans for their support.

This news continues a legacy of success for the series. 2019’s A Plague Tale: Innocence climbed to number 9 in the UK Top Sellers chart and also surpassed 1 million total sales in just over a year. A Plague tale: Requiem shot past the same bar in just a month.

If you want, you can watch us cheat about The Plague Tale: Requiem right here!

Why this is so can be due to many factors. For one thing, the critical reception of A Plague Tale Requiem has been overwhelmingly positive. Not only was it praised in our own rave review, but the game also received a Metacritic score of 85. Add to that A Plague Tale; Innocence’s established quality and it’s possible the sequel had a lot of hype surrounding it.

Additionally, October was a month without much competition for A Plague Tale: Innocence. Scorn, as the only other narrative title, was great, but it lacked the AAA appeal and established fan base of A Plague Tale: Requiem. Overwatch 2 was a controversial multiplayer shooter. Gotham Knights was jerking off.

You can imagine how good the Focus Entertainment team feels. Not only has it exceeded the bar it set for itself, it has done so with flying colours. It’s always good to see these big narrative-driven adventures doing well in the current landscape, with massive battle royales and new live-service games popping up all the time. We’re just wondering how long it’ll be before the game shoots over two million.

Speaking of narrative adventures, have you heard of a little game called God of War Ragnarok? We have a review of it live and ready for you here for your reading pleasure.

https://www.vg247.com/a-plague-tale-requiem-passes-1-million-sales-devs-celebrate A Plague Tale: Requiem Passes 1 Million Mark – Developers Celebrate



Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button